NASDAQ: IMCR
Immunocore Holdings PLC Stock Ownership - Who owns Immunocore Holdings?

Insider buying vs selling

Have Immunocore Holdings PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Baker Bros Advisors LPDirector2025-03-1760,110$29.74
$1.79MBuy
Baker Bros Advisors LPDirector2025-03-17646,290$29.74
$19.22MBuy
Baker Bros Advisors LPDirector2025-03-178,589$29.56
$253.89kBuy
Baker Bros Advisors LPDirector2025-03-1792,349$29.56
$2.73MBuy

1 of 1

IMCR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMCR insiders and whales buy or sell their stock.

IMCR Shareholders

What type of owners hold Immunocore Holdings PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc13.38%6,700,208$204.16MInstitution
Wellington Management Group LLP13.22%6,617,055$201.62MInstitution
Rtw Investments LP9.73%4,869,798$148.38MInstitution
Fmr LLC9.62%4,817,699$146.80MInstitution
Primecap Management Co5.33%2,668,550$81.31MInstitution
Price T Rowe Associates Inc4.37%2,187,530$66.65MInstitution
Baker Bros Advisors LP4.28%2,144,060$65.33MInsider
Tang Capital Management LLC3.11%1,555,600$47.40MInstitution
Baker Bros Advisors LP3.03%1,515,318$46.17MInstitution
General Atlantic LP2.52%1,261,684$38.44MInstitution

1 of 3

IMCR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMCR91.87%4.35%Net BuyingNet Buying
VERA66.31%33.69%Net SellingNet Selling
MNKD34.91%65.09%Net SellingNet Selling
GPCR35.24%12.56%Net Buying
EWTX86.39%13.61%Net BuyingNet Buying

Immunocore Holdings Stock Ownership FAQ

Who owns Immunocore Holdings?

Immunocore Holdings (NASDAQ: IMCR) is owned by 91.87% institutional shareholders, 4.35% Immunocore Holdings insiders, and 3.78% retail investors. Baker Bros Advisors LP is the largest individual Immunocore Holdings shareholder, owning 2.14M shares representing 4.28% of the company. Baker Bros Advisors LP's Immunocore Holdings shares are currently valued at $64.54M.

If you're new to stock investing, here's how to buy Immunocore Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.